Loading [Contrib]/a11y/accessibility-menu.js
JHEOR
Menu
Articles
Author Correction
Autoimmune Diseases
Cardiovascular Conditions
Commentary
Correspondence
Dermatological Diseases
Endocrine Diseases
Gastrointestinal Conditions
General Indications
Hematology
Hereditary Genetic Disorders
Infectious Diseases
Methodology and Healthcare Policy
Nephrologic/Hepatologic Conditions
Neurological Diseases
Oncology
Ophthalmology
Other Conditions
Perspective
Psychological Conditions
Respiratory Diseases
Trauma Induced Conditions
Urological/Gynecological Diseases
All
For Authors
Editorial Board
About
Issues
Blog
Journal Policies
For Reviewers
search
Sorry, something went wrong. Please try your search again.
×
Articles
Blog posts
RSS Feed
Enter the URL below into your favorite RSS reader.
https://jheor.org/feed
×
Nephrologic/Hepatologic Conditions
Vol. 1, Issue 3, 2014
December 18, 2013 EDT
Cost-effectiveness of Triple Therapy with Telaprevir for Chronic Hepatitis C Virus Patients in Germany
Jona T. Stahmeyer
,
Svenja Schauer
,
Siegbert Rossol
,
Hans Heinrich Wedemeyer
,
Daniel Wirth
,
Florence Bianic
,
Christian Krauth
,
germany
markov model
triple-therapy
cost-effectiveness analysis
hepatitis c
Copyright Logo
ccby-4.0
JHEOR
1.
Stahmeyer JT, Schauer S, Rossol S, et al. Cost-effectiveness of Triple Therapy with Telaprevir for Chronic Hepatitis C Virus Patients in Germany.
JHEOR
. 2013;1(3):239-253.
Save article as...
▾
PDF
XML
Citation (BibTeX)
View more stats